Drupal.behaviors.print = function(context) {window.print();window.close();}>
Agenix Licenses Tyrian Dx Technology to Develop Microarray Device
October 25, 2012
Agenix Licenses Tyrian Dx Technology to Develop Microarray Device
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Gentel Licenses OHSU Viral Antigens for its Simian Assay
August 29, 2011 / GenomeWeb Daily News
Signature Dx to Use Affymetrix Chips for Cancer Test Development
June 28, 2010 / GenomeWeb Daily News
Skyline Licenses TrovaGene Biomarker for AML
June 21, 2010 / GenomeWeb Daily News
CGI Pledges to Launch Two More Array Tests This Year after 'Busy' Q1
May 28, 2013 / BioArray News
NanoString Takes Option to Liver Cancer Gene Signature for Possible Assay Development
April 17, 2013 / GenomeWeb Daily News